• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按糖尿病风险因素分层的糖尿病前期、未诊断糖尿病和2型糖尿病发病的多基因风险

Polygenic Risk of Prediabetes, Undiagnosed Diabetes, and Incident Type 2 Diabetes Stratified by Diabetes Risk Factors.

作者信息

Liu Xiaonan, Collister Jennifer A, Clifton Lei, Hunter David J, Littlejohns Thomas J

机构信息

Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire OX3 7LF, UK.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

出版信息

J Endocr Soc. 2023 Jan 30;7(4):bvad020. doi: 10.1210/jendso/bvad020. eCollection 2023 Feb 9.

DOI:10.1210/jendso/bvad020
PMID:36819459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9933896/
Abstract

CONTEXT

Early diagnosis of type 2 diabetes is crucial to reduce severe comorbidities and complications. Current screening recommendations for type 2 diabetes include traditional risk factors, primarily body mass index (BMI) and family history, however genetics also plays a key role in type 2 diabetes risk. It is important to understand whether genetic predisposition to type 2 diabetes modifies the effect of these traditional factors on type 2 diabetes risk.

OBJECTIVE

This work aimed to investigate whether genetic risk of type 2 diabetes modifies associations between BMI and first-degree family history of diabetes with 1) prevalent prediabetes or undiagnosed diabetes; and 2) incident confirmed type 2 diabetes.

METHODS

We included 431 658 individuals aged 40 to 69 years at baseline of multiethnic ancestry from the UK Biobank. We used a multiethnic polygenic risk score for type 2 diabetes (PRS) developed by Genomics PLC. Prediabetes or undiagnosed diabetes was defined as baseline glycated hemoglobin greater than or equal to 42 mmol/mol (6.0%), and incident type 2 diabetes was derived from medical records.

RESULTS

At baseline, 43 472 participants had prediabetes or undiagnosed diabetes, and 17 259 developed type 2 diabetes over 15 years follow-up. Dose-response associations were observed for PRS with each outcome in each category of BMI or first-degree family history of diabetes. Those in the highest quintile of PRS with a normal BMI were at a similar risk as those in the middle quintile who were overweight. Participants who were in the highest quintile of PRS and did not have a first-degree family history of diabetes were at a similar risk as those with a family history who were in the middle category of PRS.

CONCLUSION

Genetic risk of type 2 diabetes remains strongly associated with risk of prediabetes, undiagnosed diabetes, and future type 2 diabetes within categories of nongenetic risk factors. This could have important implications for identifying individuals at risk of type 2 diabetes for prevention and early diagnosis programs.

摘要

背景

2型糖尿病的早期诊断对于降低严重合并症和并发症至关重要。当前2型糖尿病的筛查建议包括传统风险因素,主要是体重指数(BMI)和家族史,然而遗传学在2型糖尿病风险中也起着关键作用。了解2型糖尿病的遗传易感性是否会改变这些传统因素对2型糖尿病风险的影响很重要。

目的

这项研究旨在调查2型糖尿病的遗传风险是否会改变BMI与糖尿病一级家族史之间与1) 糖尿病前期或未诊断糖尿病的患病率;以及2) 确诊的2型糖尿病发病率之间的关联。

方法

我们纳入了英国生物银行中431658名基线年龄在40至69岁之间的多民族血统个体。我们使用了由Genomics PLC开发的2型糖尿病多民族多基因风险评分(PRS)。糖尿病前期或未诊断糖尿病定义为基线糖化血红蛋白大于或等于42 mmol/mol(6.0%),2型糖尿病发病率来自医疗记录。

结果

在基线时,43472名参与者患有糖尿病前期或未诊断糖尿病,17259名在15年随访期间患2型糖尿病。在BMI或糖尿病一级家族史的每一类中,观察到PRS与每种结果之间的剂量反应关联。PRS处于最高五分位数且BMI正常的人与超重的中间五分位数的人风险相似。PRS处于最高五分位数且没有糖尿病一级家族史的参与者与有家族史且处于PRS中间类别的参与者风险相似。

结论

在非遗传风险因素类别中,2型糖尿病的遗传风险仍然与糖尿病前期、未诊断糖尿病和未来2型糖尿病的风险密切相关。这对于识别有2型糖尿病风险的个体以进行预防和早期诊断计划可能具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3780/9933896/3c146dd0e379/bvad020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3780/9933896/3c146dd0e379/bvad020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3780/9933896/3c146dd0e379/bvad020f1.jpg

相似文献

1
Polygenic Risk of Prediabetes, Undiagnosed Diabetes, and Incident Type 2 Diabetes Stratified by Diabetes Risk Factors.按糖尿病风险因素分层的糖尿病前期、未诊断糖尿病和2型糖尿病发病的多基因风险
J Endocr Soc. 2023 Jan 30;7(4):bvad020. doi: 10.1210/jendso/bvad020. eCollection 2023 Feb 9.
2
A Polygenic Score for Type 2 Diabetes Improves Risk Stratification Beyond Current Clinical Screening Factors in an Ancestrally Diverse Sample.在一个具有不同祖先背景的样本中,2型糖尿病的多基因评分在当前临床筛查因素之外改善了风险分层。
Front Genet. 2022 Apr 26;13:871260. doi: 10.3389/fgene.2022.871260. eCollection 2022.
3
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).脂肪肝指数可预测前驱糖尿病、2型糖尿病和非酒精性脂肪性肝病(NAFLD)的发病风险。
Ann Med. 2021 Dec;53(1):1256-1264. doi: 10.1080/07853890.2021.1956685.
4
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.糖化血红蛋白、糖尿病前期与心血管疾病的关联:来自英国生物库的研究数据。
Diabetes Care. 2020 Feb;43(2):440-445. doi: 10.2337/dc19-1683. Epub 2019 Dec 18.
5
Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study.英国生物库中体重指数与 2 型糖尿病关联的同质性:一项孟德尔随机化研究。
PLoS Med. 2019 Dec 10;16(12):e1002982. doi: 10.1371/journal.pmed.1002982. eCollection 2019 Dec.
6
The prevalence of undiagnosed Prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada.加拿大西部青少年族群中未确诊的糖尿病前期/2型糖尿病、高血压前期/高血压和肥胖症的患病率。
BMC Pediatr. 2020 Jan 23;20(1):31. doi: 10.1186/s12887-020-1924-6.
7
Rural-Urban Differences in Risk Factors for Prediabetes and Undiagnosed Diabetes Among Adult Dwellers in Selected Yoruba-Speaking Parts of Nigeria: A Glycated Haemoglobin-Based Population Screening.尼日利亚部分讲约鲁巴语地区成年居民中基于糖化血红蛋白的人群筛查:农村-城市间糖尿病前期和未确诊糖尿病风险因素的差异。
West Afr J Med. 2024 May 31;41(5):583-591.
8
Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.加拿大(2007-2011 年)基于空腹血糖和糖化血红蛋白筛查标准的糖尿病前期和未确诊糖尿病的流行率。
Diabetes Care. 2015 Jul;38(7):1299-305. doi: 10.2337/dc14-2474. Epub 2015 Apr 7.
9
Unmasking the Risk Factors Associated with Undiagnosed Diabetes and Prediabetes in Ghana: Insights from Cardiometabolic Risk (CarMeR) Study-APTI Project.揭开加纳未诊断糖尿病和糖尿病前期相关风险因素的面纱:来自心血管代谢风险(CarMeR)研究-APTI 项目的见解。
Int J Environ Res Public Health. 2024 Jun 26;21(7):836. doi: 10.3390/ijerph21070836.
10
Identification of Individuals With Undiagnosed Diabetes and Pre-Diabetes in a Danish Cohort Attending Dental Treatment.在接受牙科治疗的丹麦队列中识别未诊断出的糖尿病和糖尿病前期个体。
J Periodontol. 2016 Apr;87(4):395-402. doi: 10.1902/jop.2016.150266. Epub 2016 Jan 8.

引用本文的文献

1
The Clock is Still Ticking: Tirzepatide and the Myth of Halting the Natural History of Type 2 Diabetes.时钟仍在滴答作响:替尔泊肽与终止2型糖尿病自然病程的神话
Diabetes Ther. 2025 Aug;16(8):1529-1531. doi: 10.1007/s13300-025-01759-y. Epub 2025 Jun 17.
2
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.多基因评分在2型糖尿病中的临床应用:挑战与机遇
Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419-1.
3
Insights into optimal BMI from the GlasVEGAS study.格拉斯哥血管研究对最佳体重指数的见解。

本文引用的文献

1
Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.人体测量学和肥胖指标与 2 型糖尿病风险:队列研究的系统评价和剂量反应荟萃分析。
BMJ. 2022 Jan 18;376:e067516. doi: 10.1136/bmj-2021-067516.
2
Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care.英国生物银行糖化血红蛋白测量值与关联的初级医疗记录中的测量值不同:对整合研究和常规临床护理中的生化数据的启示。
Int J Epidemiol. 2022 Jun 13;51(3):1022-1024. doi: 10.1093/ije/dyab265.
3
Nat Metab. 2024 Aug;6(8):1435-1437. doi: 10.1038/s42255-024-01088-7.
4
Assessing the importance of primary care diagnoses in the UK Biobank.评估初级保健诊断在英国生物库中的重要性。
Eur J Epidemiol. 2024 Feb;39(2):219-229. doi: 10.1007/s10654-023-01095-0. Epub 2024 Jan 16.
5
Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms.2 型糖尿病成人的代谢生物标志物:PPAR-γ2 和 PPAR-β/δ 多态性的作用。
Biomolecules. 2023 Dec 14;13(12):1791. doi: 10.3390/biom13121791.
6
Defying the Odds: Conquering Prediabetes for a Diabetes-Free Tomorrow.战胜困难:攻克糖尿病前期,迎接无糖尿病的明天。
Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):273-276. doi: 10.4103/2230-8210.388224. Epub 2023 Aug 29.
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.
国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
4
Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.筛查糖尿病前期和 2 型糖尿病:美国预防服务工作组推荐声明。
JAMA. 2021 Aug 24;326(8):736-743. doi: 10.1001/jama.2021.12531.
5
Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels.增强型多基因风险评分与生活方式对心血管疾病、糖尿病和血脂水平的交互作用。
Circ Genom Precis Med. 2021 Feb;14(1):e003128. doi: 10.1161/CIRCGEN.120.003128. Epub 2021 Jan 12.
6
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank.尽量减少可能影响英国生物银行生化检测数据的系统和随机变异来源的流行病学影响的方法。
Wellcome Open Res. 2021 Jan 4;5:222. doi: 10.12688/wellcomeopenres.16171.2. eCollection 2020.
7
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.在一项多血统荟萃分析中,对 140 万参与者进行研究,发现了 318 个 2 型糖尿病和相关血管结局的新风险位点。
Nat Genet. 2020 Jul;52(7):680-691. doi: 10.1038/s41588-020-0637-y. Epub 2020 Jun 15.
8
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.2 型糖尿病与冠心病关系的遗传学研究进展。
Circ Res. 2020 May 22;126(11):1526-1548. doi: 10.1161/CIRCRESAHA.119.316065. Epub 2020 May 21.
9
Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe.社会人口学和生活方式相关的 2 型糖尿病高危人群识别风险因素:以欧洲数据为主的叙述性综述。
BMC Endocr Disord. 2020 Mar 12;20(Suppl 1):134. doi: 10.1186/s12902-019-0463-3.
10
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine.用于糖尿病诊断和精准医学的遗传风险评分。
Endocr Rev. 2019 Dec 1;40(6):1500-1520. doi: 10.1210/er.2019-00088.